Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Kinase inhibitors under study at Bayer

Sep. 16, 2003

Preclinical results reported for AZ-CINN-310 in breast cancer

Sep. 16, 2003

Phase III results for Genasense plus chemotherapy in malignant melanoma

Sep. 15, 2003

Javlor enters two new phase III trials in NSCLC and bladder cancer

Sep. 15, 2003

OncoGenex and Isis expand antisense drug development partnership

Sep. 15, 2003

Rexin-G designated an orphan drug for pancreatic cancer

Sep. 12, 2003

Clofarabine granted fast track status for pediatric leukemia

Sep. 12, 2003

Aventis and Regeneron enter global agreement for VEGF Trap

Sep. 12, 2003

Novel Jak kinase inhibitors for use in inflammation and cancer

Sep. 12, 2003

New antitumor, antibacterial and antifungal agents from Penicillium sp.

Sep. 10, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...